Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2005; 11(46): 7242-7247
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7242
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7242
Table 3 Tumor classification, distribution, and differentiation in rats treated with DMH with or without endostatin
| Treatment | Tumor | Classification (%) | Distribution in colon (%) | Differentiated carcinoma (%) | |||||
| number | Adenoma | Carcinoma | Proximal | Middle | Distal | Well | Moderately | Poorly | |
| DMH+endostatin | 25 | 16 (64) | 9 (36) | 12 (48) | 9 (36) | 4 (16) | 6 (66.7) | 3 (33.3)a | 0 |
| DMH+ L lactis | 24 | 15 (62.5) | 9 (37.5) | 10 (41.7) | 12 (50) | 2 (8.3) | 6 (66.7) | 3 (33.3)a | 0 |
| DMH | 40 | 27 (67.5) | 13 (32.5) | 15 (37.5) | 19 (47.5) | 6 (15) | 3 (23.1) | 10 (76.9) | 0 |
-
Citation: Li W, Li CB. Effect of oral
Lactococcus lactis containing endostatin on 1, 2-dimethylhydrazine-induced colon tumor in rats. World J Gastroenterol 2005; 11(46): 7242-7247 - URL: https://www.wjgnet.com/1007-9327/full/v11/i46/7242.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i46.7242